Spruce Biosciences, Inc. (SPRB)
NASDAQ·Healthcare·Biotechnology
$44.49
-4.43%
Mkt Cap $36.05M
Analyst Ratings
No recent rating data.
Price Target (8 analysts)
$131.33
Range $104.00 – $150.00
Implied Upside
+195.2%
Consensus $131.33 vs current $44.49
NASDAQ·Healthcare·Biotechnology
$44.49
-4.43%
Mkt Cap $36.05M
No recent rating data.
Price Target (8 analysts)
$131.33
Range $104.00 – $150.00
+195.2%
Consensus $131.33 vs current $44.49